Characterization of the probiotic yeast Saccharomyces boulardii in the healthy mucosal immune system

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Hudson, Lauren E ^a   McDermott, Courtney D ^a   Stewart, Taryn P ^a   Hudson, William H ^a   Rios, Daniel ^a   Fasken, Milo B ^a   Corbett, Anita H ^a   Lamb, Tracey J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FUNGAL CELL WALL; FUNGAL GENE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTESTINE; INTESTINE MUCOSA; MESENTERY LYMPH NODE; MOUSE; MUCOSAL IMMUNE SYSTEM; NONHUMAN; PEYER PATCH; RNA SEQUENCE; SACCHAROMYCES BOULARDII; SPECIES DIFFERENTIATION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ENZYME IMMUNOASSAY; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; MOLECULAR GENETICS; MUCOSA; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; FEMALE; FLOW CYTOMETRY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; IMMUNE SYSTEM; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICROBIOTA; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SACCHAROMYCES; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84963761446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153351     Document Type: Article

References (57)

1. Hamedi H, Misaghi A, Modarressi MH, Salehi TZ, Khorasanizadeh D, Khalaj V. Generation of a Uracil Auxotroph Strain of the Probiotic Yeast Saccharomyces boulardii as a Host for the Recombinant Protein Production. Avicenna J Med Biotechnol. 2013;5:29-34. PMID: 23626874
2. Hudson LE, Fasken MB, McDermott CD, McBride SM, Kuiper EG, Guiliano DB, et al. Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii. PLoS One. 2014;9:1-12. doi:10.1371/journal.pone.0112660
3. Pothoulakis C. Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther. 2009;30:826-33. doi:10.1111/j.1365-2036.2009.04102.x PMID: 19706150
4. Bonaccorsi I, Buda C, Campana S, De Pasquale C, Oliveri D, Cascio A, et al. Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption. Immunol Lett. 2015; doi:10.1016/j.imlet.2015.11.008
5. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141-53. doi:10.1038/nri3608 PMID: 24566914
6. Cerutti A, Rescigno M. The Biology of Intestinal Immunoglobulin A Responses. Immunity. 2008;8:740-750. doi:10.1016/j.immuni.2008.05.001
7. Farache J, Koren I, Milo I, Gurevich I, Kim K-W, Zigmond E, et al. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity. 2013;38:581-95. doi:10.1016/j.immuni.2013.01.009 PMID: 23395676
8. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop K A., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature. 2012;483:345-349. doi:10. 1038/nature10863 PMID: 22422267
9. Schulz O, Pabst O. Antigen sampling in the small intestine. Trends Immunol. 2012;1-7. doi:10.1016/j. it.2012.09.006
10. Klis FM, Boorsma A, De Groot PWJ. Cell wall construction in Saccharomyces cerevisiae. Yeast. 2006;23:185-202. doi:10.1002/yea.1349 PMID: 16498706
11. Lesage G, Bussey H. Cell Wall Assembly in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 2006;70:317-343. doi:10.1128/MMBR.00038-05 PMID: 16760306
12. Orlean P. Architecture and Biosynthesis of the Saccharomyces cerevisiae Cell Wall. Genetics. 2012;192:775-818. doi:10.1534/genetics.112.144485 PMID: 23135325
13. De Jesus M, Ostroff GR, Levitz SM, Bartling TR, Mantis NJ. A population of langerin-positive dendritic cells in murine Peyer's patches involved in sampling beta-glucan microparticles. PLoS One. 2014;9. doi:10.1371/journal.pone.0091002
14. Perez-Garcia LA, Diaz-Jimenez DF, Lopez-Esparza A, Mora-Montes HM. Glycobiology Role of Cell Wall Polysaccharides during Recognition of Candida albicans by the Innate Immune System. Glycobiology. 2012;1:1-7. doi:10.4172/jgb.1000102
15. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275-288. doi:10.1038/nri2939 PMID: 21394104
16. Levitz SM, Specht CA. Recognition of the fungal cell wall by innate immune receptors. Curr Fungal Infect Rep. 2009;3:179-185. doi:10.1007/s12281-009-0023-9
17. Jawhara S, Habib K, Maggiotto F, Pignede G, Vandekerckove P, Maes E, et al. Modulation of intestinal inflammation by yeasts and cell wall extracts: Strain dependence and unexpected anti-inflammatory role of glucan fractions. PLoS One. 2012;7:1-15. doi:10.1371/journal.pone.0040648
18. De Smet R, Demoor T, Verschuere S, Dullaers M, Ostroff GR, Leclercq G, et al. â-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination. J Control Release. 2013;172:671-678. doi:10.1016/j.jconrel.2013.09.007 PMID: 24041710
19. Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust Stimulation of Humoral and Cellular Immune Responses following Vaccination with Antigen-Loaded â-Glucan Particles. MBio. 2010;1:1-7. doi:10.1128/mBio.00164-10. Editor
20. Buts JP, Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci. 1990;35:251-6. PMID: 2302983
21. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, La Mont JT, et al. Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice. Infect Immun. 2001;69. doi:10.1128/IAI.69.4.2762
22. Rodrigues A, Cara D, Fretez S, Cunha F, Vieira E, Nicoli J, et al. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol. 2000;89:404-14. doi:10.1046/j.1365-2672.2000.01128.x PMID: 11021572
23. Cunningham F, Amode M, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2015. Nucleic Acids Res. 2015;43:D662-D669. doi:10.1093/nar/gku1010 PMID: 25352552
24. Soderlund C, Nelson W, Shoemaker A, Paterson A. SyMAP: A system for discovering and viewing syntenic regions of FPC maps. Genome Res. 2006;16:1159-68. doi:10.1101/gr.5396706 PMID: 16951135
25. Khatri I, Akhtar A, Kaur K, Tomar R, Prasad GS, Ramya TN, et al. Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii. Gut Pathog. 2013;5:30. doi:10. 1186/1757-4749-5-30 PMID: 24148866
26. Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, Chan ET, et al. Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic Acids Res. 2012;40:D700-D705. doi:10.1093/nar/gkr1029 PMID: 22110037
27. Du Bois M, Gilles K, Hamilton J, Rebers P, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28:350-356. doi:10.1021/ac60111a017
28. Manzi A, Esko J. Direct chemical analysis of glycoconjugates for carbohydrates. Curr Protoc Mol Biol. 2001;32:17-9.1-17.9.11. doi:10.1002/0471142727.mb1709s32
29. Hudson LE, Stewart TP, Fasken MB, Corbett AH, Lamb TJ. Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice. J Vis Exp. 2016;1-13. doi:10.3791/53453
30. Fischer AH, Jacobson KA, Rose J, Zeller R. Cryosectioning Tissues. Cold Spring Harb Protoc. 2008;3:1-3. doi:10.1101/pdb.prot4991
31. Matar CG, Anthony NR, O'Flaherty BM, Jacobs NT, Priyamvada L, Engwerda CR, et al. Gammaherpesvirus Co-infection with Malaria Suppresses Anti-parasitic Humoral Immunity. PLOS Pathog. 2015;11:e1004858. doi:10.1371/journal.ppat.1004858 PMID: 25996913
32. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36. doi:10.1186/gb-2013-14-4-r36 PMID: 23618408
33. Anders S, Pyl PT, Huber W. HTSeq A Python framework to work with high-throughput sequencing data. Bioinformatics. 2014;31:166-169. doi:10.1101/002824 PMID: 25260700
34. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi:10.1186/s13059-014-0550-8 PMID: 25516281
35. McFarland L V. Saccharomyces boulardii Is Not Saccharomyces cerevisiae. Clin Infect Dis. 1996;22:200-201. PMID: 8825013
36. Christensen HR, Frøkiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002;168:171-178. doi:10.4049/jimmunol.168.1.171 PMID: 11751960
37. Santos B, Snyder M. Sbe2p and sbe22p, two homologous Golgi proteins involved in yeast cell wall formation. Mol Biol Cell. 2000;11:435-452. doi:10.1091/mbc.11.2.435 PMID: 10679005
38. O'Reilly MK, Zhang G, Imperiali B. In vitro evidence for the dual function of Alg2 and Alg11: Essential mannosyltransferases in N-linked glycoprotein biosynthesis. Biochemistry. 2006;45:9593-9603. doi:10.1021/bi060878o PMID: 16878994
39. Lin CP-C, Kim C, Smith SO, Neiman AM. A highly redundant gene network controls assembly of the outer spore wall in S. cerevisiae. PLoS Genet. 2013;9:e1003700. doi:10.1371/journal.pgen. 1003700 PMID: 23966878
40. Muthukumar G, Suhng S-H, Magee P, Jewell RD, Primerano DA. The Saccharomyces cerevisiae SPR1 gene encodes a sporulation-specific exo-1, 3-beta-glucanase which contributes to ascospore thermoresistance. J Bacteriol. 1993;175:386-394. PMID: 8419289
41. Stack HM, Kearney N, Stanton C, Fitzgerald GF, Ross RP. Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli. Appl Environ Microbiol. 2010;76:500-507. doi:10.1128/AEM.01524-09 PMID: 19933353
42. Letscher-Bru V, Herbrecht R. Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother. 2003;51:513-521. doi:10.1093/jac/dkg117 PMID: 12615851
43. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol. 2011;29:273-93. doi:10.1146/annurev-immunol-031210-101317 PMID: 21219173
44. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313-323. doi:10.1038/nri2614 PMID: 19343057
45. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN V, Shanman R, et al. Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea. JAMA. 2012;307:1959-1969. doi:10.1001/jama.2012.3507 PMID: 22570464
46. Michael S, Keubler LM, Smoczek A, Meier M, Gunzer F, Pöhlmann C, et al. Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging. Inflamm Bowel Dis. 2012;19:185-93. doi:10.1002/ibd.23006
47. Jahn H-U, Ullrich R, Schneider T, Liehr R-M, Schieferdecker HL, Holst H, et al. Immunological and trophical effects of Saccharomyces boulardi on the small intestine in healthy human volunteers. Digestion. 1996;57:95-104. PMID: 8786007
48. Kim S-H, Jang Y-S. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med. 2014;46:e85. doi:10.1038/emm.2013.165 PMID: 24626171
49. Lo DD. Mucosal vaccine delivery: is M cell-targeted delivery effective in the mucosal lumen? Expert Opin Drug Deliv. 2013;10:157-61. doi:10.1517/17425247.2013.740008 PMID: 23252467
50. Shakweh M, Ponchel G, Fattal E. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin Drug Deliv. 2004;1:141-163. doi:10.1517/17425247.1.1.141 PMID: 16296726
51. Sun J, Shao Z, Zhao H, Nair N, Wen F, Xu J-H, et al. Cloning and characterization of a panel of constitutive promoters for applications in pathway engineering in Saccharomyces cerevisiae. Biotechnol Bioeng. 2012;109:2082-92. doi:10.1002/bit.24481 PMID: 22383307
52. Walter J, Heng NCK, Hammes WP, Loach DM, Tannock GW, Hertel C. Identification of Lactobacillus reuteri genes specifically induced in the mouse gastrointestinal tract. Appl Environ Microbiol. 2003;69:2044-2051. doi:10.1128/AEM.69.4.2044 PMID: 12676681
53. Castex F, Corthier G, Jouvert S, Elmer GW, Lucas F, Bastide M. Prevention of Clostridium difficileinduced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study. J Gen Microbiol. 1990;136:1085-1089. doi:10.1099/00221287-136-6-1085 PMID: 2200843
54. Martins FS, Dalmasso G, Arantes RME, Doye A, Lemichez E, Lagadec P, et al. Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS One. 2010;5:e8925. doi:10.1371/journal.pone.0008925 PMID: 20111723
55. Goldenberg J, Lytvyn L, Steurich J, Parkin P, Manhant S, Johnston B. Probiotics for the prevention of pediatric antibiotic-associated diarrhea (Review). Cochrane Database Syst Rev. 2015;1-4. doi:10. 1002/14651858. CD004827.pub4
56. Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD. Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice. MBio. 2014;5:1-9. doi:10.1128/mBio.01011-14. Editor
57. Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res. 1986;20:192-6. doi:10.1203/00006450-198602000-00020 PMID: 3080730